ETF Strategies to Ride the Year-End Santa Rally

 | Dec 27, 2021 01:20AM ET

Santa Claus has been kind to Wall Street as the market ended the last week in the green despite initial weakness due to Omicron fears. The Dow Jones Industrial Average increased about 1.6%. The S&P 500 jumped 2.3% and the Nasdaq Composite rose 3.2% in the last week ending Dec 24.

Reopening plays in sectors like airlines, cruise lines and entertainment saw increased investor attention. Carnival (NYSE:CUK) and Hilton Worldwide climbed about 16% and 9.8%, respectively in the holiday-shortened last week.

Investors gained optimism from some of President Joe Biden’s encouraging announcements. Biden stated that booster shots provide strong protection against COVID-19 (per a CNBC article). He also mentioned that the United States will not slip into the intense pandemic conditions faced during March 2020.

Updating about his preparations for the healthcare infrastructure and arrangements, Biden mentioned that the White House is buying 500 million at-home COVID-19 tests that will be available at free of cost for Americans from 2022 (as stated in a CNBC article). Biden also mentioned that 1000 medical personnel will be allocated from the military to assist hospitals if the situation gets severe in January and February.

Notably, three studies from South Africa, England and Scotland demonstrated that the Omicron variant is milder in comparison to the other variants and has been observed to result in lower chances of hospitalization (per a CNBC article).

Moreover, the emergency use authorization (EUA) for Pfizer Inc.’s (NYSE:PFE) antiviral COVID-19 pill, PAXLOVID has relaxed concerns regarding Omicron to some extent. Pfizer can begin delivering PAXLOVIDin the United States on an immediate basis. It is worth noting that in November, Pfizer had informed about signing an agreement with the U.S. government to supply 10 million treatment courses of PAXLOVID. The delivery will be completed in 2022. The FDA had also granted nod to Merck’s antiviral pill for Covid-19.

h3 ETF Strategies to Follow/h3

Here we discuss certain ETF strategies to help investors gain from optimism surrounding the easing Omicron variant concerns amid a recovering U.S. economy:

h3 Play the Momentum ETFs/h3

While the broader stock market is expected to gain on optimism surrounding the rebounding U.S. economy and accelerated distribution of coronavirus vaccine, momentum investing will likely take center stage as investors seek greater returns in the short term. Momentum investing looks to fetch profits from hot stocks that have shown an uptrend over the past few weeks or months. Investors can consider iShares MSCI USA Momentum Factor ETF A Quick Guide to the 25 Cheapest ETFs ).


Want key ETF info delivered straight to your inbox?

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week.

Get it free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Zacks Investment Research

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes